Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-17

Clinical Trial Update: Rifaximin in Minimal Hepatic Encephalopathy [NA]

View source ↗

Summary

Clinical trial update for rifaximin in minimal hepatic encephalopathy has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rifaximin (rifaximin)

Snippet

Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center | Conditions: Hepatic Encephalopathy | NA | Status: COMPLETED | Results posted: 2020-12-17